SuperTruth announces acquisition of imaware to revolutionize AI data management and health outcomes
Acquiring Company
SuperTruth
Acquired Company
imaware
Description
SuperTruth, a first-party data company, has announced the acquisition of imaware, a leader in at-home testing and health wellness insights infrastructure. With this acquisition, SuperTruth aims to revolutionize AI data management and enable better health outcomes by unifying fragmented health data and empowering enterprise-focused systems in the healthcare industry to understand and manage data in more accurate and impactful ways.
Quick answer
SuperTruth is acquiring imaware, announced December 18, 2024. SuperTruth is based in New York, New York, United States.
- How much did SuperTruth pay for imaware?
- The deal value was not disclosed.
- What does SuperTruth do?
- SuperTruth is a first-party data company focused on developing and augmenting technology, catalyzing investment where innovation and data intersect.
- Where are SuperTruth and imaware based?
- SuperTruth is based in New York, New York, United States. imaware is based in Austin, Texas, United States.
- Who are the decision-makers at SuperTruth?
- Fundz holds 3 contacts at SuperTruth. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Analytics and Data Center
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- ActiGraph completes acquisition of Biofourmis Connect to enhance digital health solutions (January 7, 2025)
- OraSure Technologies completes acquisition of Sherlock Biosciences, Inc. to expand its innovation pipeline in molecular testing market (December 19, 2024)
- Lovelytics completes acquisition of Datalytics to strengthen Databricks leadership (January 30, 2025)
- Exicure, Inc. completes acquisition of GPCR Therapeutics USA Inc. to enhance its pipeline for cell and gene therapies (January 22, 2025)
- Cycle Pharmaceuticals completes acquisition of Banner Life Sciences, LLC to expand MS product portfolio (January 13, 2025)
- Quanterix Corporation to acquire Akoya Biosciences, creating a groundbreaking integrated solution for ultra-sensitive detection of protein biomarkers (January 10, 2025)
Who to call at SuperTruth, and when
When SuperTruth changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day SuperTruth raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at SuperTruth, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at SuperTruth. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment SuperTruth makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired imaware?
imaware was acquired by SuperTruth, based in New York. The deal was reported on December 18, 2024. SuperTruth is a first-party data company focused on developing and augmenting technology, catalyzing investment where innovation and data intersect. SuperTruth is privately held and operates in Information Technology.
When did SuperTruth acquire imaware?
SuperTruth's acquisition of imaware was reported on December 18, 2024. SuperTruth, a first-party data company, has announced the acquisition of imaware, a leader in at-home testing and health wellness insights infrastructure. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does imaware do?
imaware, a Texas-based health platform, delivers precise at-home diagnostic testing to help individuals take control of their health. It is privately held, operating in Biotechnology, and is based in Austin.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.